Exchange: NASDAQ·Updated 11:53 AM EDT

APTOAptose Biosciences Inc

$1.69
$0.015
(0.90%)
Today
Reported EarningsMay 13
Mkt Cap$4.31M
Vol636.00

About

Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class anticancer therapies with high safety profiles. Through its own discovery efforts, as well as partnering activities, Lorus is building a portfolio of promising anticancer drugs ranging from discovery and preclinical to clinical-proof-of concept stage. Lorus seeks suitable partners for subsequent late-stage registration trials and eventual commercialization.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
14

Frequently Asked Questions

What is Market Cap of Aptose Biosciences Inc?
What is the 52-week high for Aptose Biosciences Inc?
What is the 52-week low for Aptose Biosciences Inc?
What is Aptose Biosciences Inc stock price today?
What was Aptose Biosciences Inc stock price yesterday?
What is the PE ratio of Aptose Biosciences Inc?
What is the Price-to-Book ratio of Aptose Biosciences Inc?
What is the 50-day moving average of Aptose Biosciences Inc?
How many employees does Aptose Biosciences Inc have?

Advertisement|Remove ads.